Maravai Lifesciences Holdings (MRVI) Finished Goods (2020 - 2026)
Maravai Lifesciences Holdings (MRVI) recorded quarterly Finished Goods of $18.6 million in Q1 2026, little changed quarter-over-quarter from $18.6 million in Q4 2025, and down 17.74% on a YoY basis from $22.7 million in Q1 2025.
Maravai Lifesciences Holdings (MRVI) Finished Goods (2020 - 2026) Analysis & Trends
Maravai Lifesciences Holdings' Finished Goods history runs 7 years deep, the most recent figure standing at $18.6 million for Q1 2026.
- In Q1 2026, Finished Goods fell 17.74% year-over-year to $18.6 million; the TTM figure through Mar 2026 stood at $18.6 million (down 17.74% YoY), while the FY2025 annual figure was $18.6 million, down 19.46% from the prior year.
- Finished Goods was $18.6 million for Q1 2026 at Maravai Lifesciences Holdings, roughly flat from $18.6 million in the prior quarter.
- In the past five years, Finished Goods ranged from a high of $23.1 million in Q4 2024 to a low of $7.3 million in Q2 2023.
- Historically, Finished Goods has averaged $16.2 million across 5 years, with a median of $18.6 million in 2026.
- The sharpest annual moves came in 2022 and 2024: Finished Goods decreased 26.16% in 2022, then soared 185.77% in 2024.
- A 5-year view of Finished Goods shows it stood at $7.7 million in 2022, then jumped by 151.15% to $19.4 million in 2023, then rose by 18.98% to $23.1 million in 2024, then decreased by 19.46% to $18.6 million in 2025, then climbed by 0.33% to $18.6 million in 2026.
- The last three Finished Goods figures came in at $18.6 million (Q1 2026), $18.6 million (Q4 2025), and $19.6 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 788,338.31 Bn | 788,338.28 Bn | - |
| 2 | Belite Bio | 56,560.00 Bn | 56,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,329.30 Bn | 17,329.30 Bn | - |
| 4 | Legend Biotech | 3,341.00 Bn | 3,340.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,727.91 Bn | 1,727.91 Bn | - |
| 6 | Evaxion A | 1,536.68 Bn | 1,536.67 Bn | - |
| 7 | Psyence Biomedical | 238.34 Bn | 238.33 Bn | - |
| 8 | Vertex Pharmaceuticals | 113.42 Bn | 106.17 Bn | 2.59 Bn |
| 9 | Abivax | 95.45 Bn | 95.45 Bn | - |
| 10 | Maravai Lifesciences Holdings | 747.50 Mn | 739.10 Mn | 33.70 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 18.63 Mn |
| Dec 31, 2025 | 18.57 Mn |
| Sep 30, 2025 | 19.59 Mn |
| Jun 30, 2025 | 19.72 Mn |
| Mar 31, 2025 | 22.65 Mn |
| Dec 31, 2024 | 23.06 Mn |
| Sep 30, 2024 | 23.00 Mn |
| Jun 30, 2024 | 20.82 Mn |
| Mar 31, 2024 | 20.25 Mn |
| Dec 31, 2023 | 19.38 Mn |
| Sep 30, 2023 | 10.15 Mn |
| Jun 30, 2023 | 7.29 Mn |
| Mar 31, 2023 | 14.30 Mn |
| Dec 31, 2022 | 7.72 Mn |
| Sep 30, 2022 | 10.47 Mn |
| Jun 30, 2022 | 9.74 Mn |
| Mar 31, 2022 | 10.81 Mn |
| Dec 31, 2021 | 10.45 Mn |
| Sep 30, 2021 | 11.47 Mn |
| Jun 30, 2021 | 6.29 Mn |